My research interests centre on IP Law and the way it is applied to biotechnological and genetic patents. There is an argument that Patent Law is currently being used as a ‘sword rather than a shield’ enabling companies and inventors to stifle and prevent access to inventions. This has resulted in stagnating innovation impacting both patients access to such innovations, along with increasing litigation time and cost. This research aims to address this balance and consider the impact of granting these patents on innovative research, access to inventions, the aggressive litigation tactics currently employed and considers the future for IP Law.